Margaret Mcloughlin - Net Worth and Insider Trading
Margaret Mcloughlin Net Worth
The estimated net worth of Margaret Mcloughlin is at least $16,240 dollars as of 2024-12-14. Margaret Mcloughlin is the Director of Quince Therapeutics Inc and owns about 8,000 shares of Quince Therapeutics Inc (QNCX) stock worth over $16,240. Details can be seen in Margaret Mcloughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Margaret Mcloughlin has not made any transactions after 2023-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Margaret Mcloughlin
Margaret Mcloughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Margaret Mcloughlin owns 1 companies in total, including Quince Therapeutics Inc (QNCX) .
Click here to see the complete history of Margaret Mcloughlin’s form 4 insider trades.
Insider Ownership Summary of Margaret Mcloughlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2023-08-08 | director |
Margaret Mcloughlin Latest Holdings Summary
Margaret Mcloughlin currently owns a total of 1 stock. Margaret Mcloughlin owns 8,000 shares of Quince Therapeutics Inc (QNCX) as of August 8, 2023, with a value of $16,240.
Latest Holdings of Margaret Mcloughlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2023-08-08 | 8,000 | 2.03 | 16,240 |
Holding Weightings of Margaret Mcloughlin
Margaret Mcloughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Margaret Mcloughlin has made a total of 3 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Quince Therapeutics Inc is the acquisition of 8,000 shares on August 8, 2023, which cost Margaret Mcloughlin around $9,840.
Insider Trading History of Margaret Mcloughlin
- 1
Margaret Mcloughlin Trading Performance
GuruFocus tracks the stock performance after each of Margaret Mcloughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Margaret Mcloughlin is 1.2%. GuruFocus also compares Margaret Mcloughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Margaret Mcloughlin within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Margaret Mcloughlin's insider trading performs compared to the benchmark.
Performance of Margaret Mcloughlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.78 | | | | | |
| Relative Return to S&P 500(%) | 16.83 | | | | | |
Margaret Mcloughlin Ownership Network
Ownership Network List of Margaret Mcloughlin
Ownership Network Relation of Margaret Mcloughlin
Margaret Mcloughlin Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Margaret Mcloughlin is the director of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Margaret Mcloughlin made 1 insider transaction in Quince Therapeutics Inc (QNCX) with a net purchase of 8,000. Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Margaret Mcloughlin Mailing Address
Above is the net worth, insider trading, and ownership report for Margaret Mcloughlin. You might contact Margaret Mcloughlin via mailing address: C/o Cortexyme, Inc., 269 East Grand Ave., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
